Building an Attractive Environment for Clinical Research in Turkey Virtual event

AIFD and EFPIA are delighted to invite you to the webinar ‘Building an Attractive Environment for Clinical Research in Turkey’, which will be held on 14 September from 14:00 to 15:15 CEST.

The study ‘Benefits of a Clinical Research Strategy for Turkey’ (2020), conducted by IQVIA and commissioned by AIFD and EFPIA, looked at the potential benefits for Turkey of a strategy to facilitate and attract further investments in clinical research. It also included recommendations on how to implement such a strategy successfully. 

Our guest speakers will exchange views on the paper’s conclusions, and on the concrete actions the Turkish government is taking to deliver on their ambition to become a regional hub for clinical research. Case studies from Belgium and Spain will also show what Turkey can learn from EU Member States’ experience, while discussing about opportunities for further cooperation in this area.


Sule Sencer Akbil, Engagement Manager, Consulting & Services, IQVIA 
Dr Koen Berden, Executive Director International Affairs, EFPIA  
Dr César Hernandez García, Head of Department, Department of Medicines for Human Use, (AEMPS, Spanish Medicines Agency)
Nathalie Lambot, Expert Public Health – Clinical Trials & Regulatory Affairs,
Assoc. Prof. Tolga Tolunay, Deputy Minister of Health, Turkey (TBC)

If you have any questions or require additional information, please contact our Communications Team at